multipl
sclerosi
ms
prototyp
inflammatori
diseas
central
nervou
system
cn
character
multifoc
area
demyelin
axon
damag
activ
glial
cell
immun
cell
infiltr
despit
intens
year
research
etiolog
neurolog
disord
remain
elus
nevertheless
abund
immun
cell
lymphocyt
product
cn
lesion
ms
patient
support
notion
ms
immunemedi
disord
import
bodi
evid
gather
ms
anim
model
experiment
autoimmun
encephalomyel
eae
point
central
contribut
lymphocyt
diseas
pathogenesi
produc
produc
interleukin
lymphocyt
target
cn
selfantigen
implic
ms
eae
pathobiolog
moreov
sever
public
suggest
lymphocyt
also
particip
develop
ms
lesion
migrat
activ
lymphocyt
peripheri
cn
identifi
crucial
step
format
ms
lesion
sever
factor
promot
cell
extravas
includ
molecul
eg
cell
adhes
molecul
implic
cellblood
brain
barrier
interact
chemokin
produc
neural
cell
final
cn
lymphocyt
need
reactiv
local
antigen
present
cell
prior
enter
parenchyma
initi
damag
investig
necessari
elucid
impact
environment
factor
eg
gut
microbiota
cn
intrins
properti
eg
microgli
activ
inflammatori
neurolog
diseas
multipl
sclerosi
ms
consid
prototyp
inflammatori
diseas
central
nervou
system
cn
neurolog
disord
affect
million
peopl
worldwid
multipl
sclerosi
intern
feder
msi
clinic
character
recurr
transient
bout
handicap
includ
loss
vision
balanc
mobil
pain
sensori
symptom
import
proport
patient
ms
experi
steadi
progress
handicap
sever
year
lead
extrem
fatigu
cognit
impair
paralysi
chronic
neurolog
diseas
enorm
physic
psychosoci
econom
burden
patient
also
famili
ms
affect
young
adult
peak
activ
life
lesion
observ
cn
ms
patient
character
multifoc
area
myelin
sheath
destruct
oligodendrocyt
death
axon
neuron
damag
activ
glial
cell
despit
decad
intens
research
etiolog
disabl
diseas
remain
unresolv
nonetheless
ms
research
commun
larg
agre
complex
interact
environment
factor
gene
lead
inflammatori
process
cn
inde
environment
factor
genet
shown
influenc
suscept
well
develop
ms
koch
et
al
vast
bodi
evid
gather
ms
patient
anim
model
point
fundament
role
immun
system
diseas
pathogenesi
wu
alvarez
genet
linkag
analys
recent
genomewid
associ
studi
ms
uncov
multipl
diseas
associ
variant
gene
relat
immun
function
sawcer
et
al
addit
cell
immun
system
macrophag
lymphocyt
product
detect
abund
ms
lesion
cerebrospin
fluid
csf
patient
ms
wu
alvarez
furthermor
immunosuppress
immunomodulatori
therapi
shown
amelior
diseas
cours
clinic
outcom
ms
cross
naismith
final
well
document
activ
myelinspecif
lymphocyt
suffici
induc
experiment
autoimmun
encephalomyel
eae
common
anim
model
ms
review
summar
current
knowledg
involv
lymphocyt
pathobiolog
ms
anim
model
defens
pathogen
provid
immun
system
compris
two
well
integr
complementari
arm
innat
immun
adapt
immun
innat
immun
system
deliv
earli
rapid
respons
adapt
immun
system
develop
respons
highli
specif
encount
infecti
agent
enhanc
subsequ
pathogen
exposur
b
lymphocyt
mediat
adapt
immun
respons
provid
longterm
protect
immatur
lymphocyt
subject
stringent
posit
neg
select
matur
thymu
prior
exit
peripheri
matur
cell
main
cell
subset
lymphocyt
also
call
helper
cell
th
lymphocyt
also
known
cytotox
cell
tc
lymphocyt
coordin
numer
immun
respons
lymphocyt
play
key
role
control
intracellular
pathogen
also
neoplast
cell
lymphocyt
express
surfac
cell
receptor
tcr
complex
compos
highli
variabl
antigen
bind
tcr
signal
protein
via
tcr
complex
lymphocyt
recogn
antigen
present
major
histocompat
complex
mhc
class
ii
molecul
wherea
lymphocyt
recogn
antigen
present
mhc
class
molecul
activ
differenti
lymphocyt
activ
cell
requir
least
two
signal
deliv
profession
antigen
present
cell
apc
tcr
recogn
peptidemhc
complex
coactiv
receptor
eg
coactiv
ligand
eg
effici
apct
cell
interact
induc
complex
cascad
intracellular
signal
trigger
matur
chang
express
profil
surfac
intracellular
molecul
prolifer
product
immun
mediat
eg
cytokin
lymphocyt
specif
environment
cue
cytokin
secret
apc
shape
differenti
lymphocyt
specif
subset
character
distinct
attribut
transcript
factor
cytokin
chemokin
receptor
etc
base
cytokin
secret
profil
three
main
subset
th
tc
lymphocyt
describ
eg
tumor
necrosi
factor
tnf
eg
interleukin
il
eg
mittruck
et
al
raphael
et
al
lymphocyt
key
compon
cellmedi
respons
provid
immun
intracellular
pathogen
cell
stimul
phagocytemedi
function
cell
directli
lyse
infect
cell
sever
mechan
includ
releas
lytic
enzym
perforin
granzym
contrast
cell
play
import
role
humoralmedi
immun
cytokin
eg
produc
cell
promot
differenti
matur
b
lymphocyt
product
antibodi
final
cell
provid
protect
certain
bacteri
fungal
infect
favor
recruit
neutrophil
activ
innat
immun
cell
effector
cell
subpopul
eg
etc
well
regulatori
cell
subset
document
mittruck
et
al
raphael
et
al
divers
lymphocyt
subset
associ
function
illustr
flexibl
compet
immun
system
effici
respond
great
varieti
pathogen
threat
follow
activ
lymphocyt
migrat
peripher
organ
mediat
immunosurveil
final
portion
activ
lymphocyt
surviv
persist
central
effector
memori
lymphocyt
memori
cell
confer
longterm
protect
enhanc
respons
upon
subsequ
challeng
unfortun
activ
cell
control
infect
tumor
also
contribut
patholog
process
despit
thymic
neg
select
matur
cell
repertoir
healthi
human
includ
lymphocyt
recogn
selfantigen
walker
abba
lymphocyt
reactiv
myelin
antigen
eg
myelin
basic
protein
mbp
proteolipid
protein
plp
myelin
oligodendrocyt
glycoprotein
mog
neuron
antigen
eg
neurofila
light
protein
found
similar
elev
proport
blood
csf
patient
ms
compar
healthi
control
ota
et
al
liblau
et
al
sun
et
al
chou
et
al
zhang
et
al
crawford
et
al
berthelot
et
al
huizinga
et
al
elong
ngono
et
al
nonetheless
notabl
number
public
advoc
myelin
specif
cell
obtain
ms
patient
display
alter
characterist
compar
detect
healthi
donor
enhanc
frequenc
highavid
cell
activ
phenotyp
allegretta
et
al
chou
et
al
zhang
et
al
vandevyv
et
al
bielekova
et
al
increas
product
proinflammatori
cytokin
tnf
sharief
thompson
strunk
et
al
zang
et
al
inject
alter
myelin
peptid
compet
nativ
myelin
peptid
consequ
alter
activ
myelinreact
cell
shown
protect
eae
develop
nicholson
et
al
gaur
et
al
anderton
et
al
genain
zamvil
subsequ
scientist
ration
antigen
specif
immunotherapi
could
potenti
benefici
ms
patient
genain
zamvil
attempt
decreas
proinflammatori
mbpspecif
cell
ms
patient
inject
alter
mbp
peptid
regrett
subgroup
patient
treatment
enhanc
mbp
reactiv
respons
trigger
develop
new
cn
inflammatori
lesion
detect
magnet
reson
imag
mri
caus
clinic
relaps
bielekova
et
al
dramat
outcom
clinic
trial
provid
direct
vivo
evid
activ
human
myelin
reactiv
lymphocyt
peripheri
lead
cn
damag
patient
ms
multipl
line
evid
collect
eae
model
establish
myelinspecif
lymphocyt
activ
peripheri
induc
cn
demyelin
diseas
inde
activ
immun
myelin
immunodomin
myelin
peptid
emulsifi
complet
freund
adjuv
trigger
develop
eae
variou
anim
speci
river
et
al
kabat
et
al
stromn
goverman
similarli
adopt
transfer
via
peripher
rout
intraperiton
intraven
activ
myelin
specif
lymphocyt
suffici
induc
eae
recipi
stromn
goverman
fletcher
et
al
mar
et
al
furthermor
activ
lymphocyt
recogn
myelin
epitop
distinct
first
target
antigen
phenomenon
coin
epitop
spread
shown
trigger
eae
relaps
mcrae
et
al
mcmahon
et
al
baxter
accordingli
differ
group
elegantli
demonstr
induct
immun
toler
myelin
peptid
prevent
emerg
relaps
eae
model
yu
et
al
vanderlugt
et
al
baxter
collect
result
support
notion
myelin
specif
cell
implic
diseas
initi
also
diseas
progress
clinic
trial
ms
patient
current
ongo
attempt
induc
toler
sever
myelin
epitop
whether
approach
lead
clinic
benefit
yet
demonstr
lutterotti
martin
detect
cnsspecif
lymphocyt
exhibit
activ
phenotyp
especi
patient
ms
suggest
lymphocyt
previou
interact
profession
apc
effici
present
cnsderiv
antigen
contrast
organ
brain
spinal
cord
contain
defin
lymphat
channel
nevertheless
lymphat
drainag
csf
interstiti
fluid
brain
parenchyma
cervic
lymph
node
take
place
laman
weller
profession
apc
dendrit
cell
shown
travel
cn
via
rostral
migratori
stream
cervic
lymph
node
peripher
cell
could
encount
cn
antigen
mohammad
et
al
matur
apc
engulf
myelin
neuron
antigen
detect
cervic
lymph
node
obtain
ms
patient
anim
marmoset
mice
affect
eae
impli
apc
posit
effici
activ
lymphocyt
fig
de
vo
et
al
van
zwam
et
al
moreov
extracellular
myelin
particl
preferenti
detect
mening
perivascular
space
ms
patient
compar
control
kooi
et
al
whether
solubl
antigen
eventu
phagocyt
present
myelin
specif
cell
still
unknown
shown
transgen
mice
express
myelin
specif
tcr
spontan
develop
eae
symptom
selfreact
cell
first
activ
cervic
lymph
node
cn
antigen
continu
present
goverman
recent
publish
data
support
notion
normal
physiolog
condit
oligodendrocyt
specif
antigen
present
cell
secondari
lymphoid
organ
harri
et
al
moreov
lymphocyt
activ
within
cervic
lymph
node
apc
present
cn
antigen
shown
acquir
specif
integrin
eg
guid
back
preferenti
brain
antigen
origin
collect
calzascia
et
al
masson
et
al
result
obtain
use
intravit
twophoton
imag
elegantli
demonstr
activ
cell
migrat
blood
vessel
cn
inflam
condit
regardless
antigen
specif
contrast
cell
licens
enter
parenchyma
follow
reactiv
local
apc
present
cognat
antigen
bartholomau
et
al
notabl
import
proport
cell
detect
ms
lesion
kivisakk
et
al
cell
observ
csf
ms
patient
jilek
et
al
ifergan
et
al
lack
loss
chemokin
receptor
cell
associ
effector
memori
phenotyp
sallusto
et
al
observ
suggest
effector
cell
enrich
inflam
cn
ms
patient
well
establish
sever
apc
present
human
mous
lesion
local
reactiv
cell
fig
includ
macrophag
microglia
dendrit
cell
greter
et
al
frohman
et
al
recent
b
cell
shown
contribut
cell
reactiv
eae
mice
pierson
et
al
fig
moreov
activ
subsequ
wave
cnsreactiv
lymphocyt
involv
diseas
relaps
perpetu
could
take
place
either
lymph
node
andor
within
inflam
cn
chronic
eae
model
relaps
sever
reduc
follow
remov
cn
drain
lymph
node
van
zwam
et
al
addit
subpopul
dendrit
cell
detect
within
inflam
brain
eae
mice
effici
activ
myelinspecif
lymphocyt
ji
et
al
collect
result
indic
cn
specif
cell
activ
either
local
cn
lymphoid
organ
vast
bodi
evid
demonstr
infecti
agent
trigger
human
mice
activ
lymphocyt
recogn
selfantigen
myelin
peptid
microbi
peptid
phenomenon
refer
molecular
mimicri
fujinami
oldston
wucherpfennig
stroming
talbot
et
al
hemmer
et
al
olson
et
al
chastain
miller
moreov
selfmolecular
mimicri
also
particip
cn
autoimmun
inde
multipl
clone
lymphocyt
expand
mog
immun
mice
carri
singl
tcr
shown
recogn
myelin
antigen
mog
axon
antigen
neurofila
krishnamoorthi
et
al
lucca
et
al
moreov
selfantigen
recognit
contribut
observ
cn
damag
krishnamoorthi
et
al
final
capac
cell
recogn
multipl
epitop
could
also
aris
dual
cell
express
two
tcr
goverman
colleagu
demonstr
viral
infect
activ
dual
cell
recogn
viral
antigen
myelin
antigen
consequ
trigger
cn
autoimmun
ji
et
al
better
understand
mechan
implic
activ
myelin
neuron
reactiv
lymphocyt
context
ms
essenti
design
therapi
specif
target
detriment
cell
blood
brain
barrier
bbb
restrict
migrat
cell
solubl
molecul
peripheri
cn
consequ
preserv
local
homeostasi
optim
environ
neuron
function
larochel
et
al
normal
physiolog
condit
leukocyt
includ
cell
cross
bbb
perform
immun
surveil
cn
contrast
massiv
infiltr
proinflammatori
leukocyt
cn
repres
earli
event
develop
ms
eae
lesion
larochel
et
al
fig
differ
step
immun
cell
extravas
includ
capturerol
activ
firm
adhes
crawl
diapedesistransmigr
engelhardt
ransohoff
rest
lymphocyt
limit
capac
invad
brain
spinal
cord
activ
lymphocyt
express
numer
molecul
includ
chemokin
receptor
adhes
molecul
integrin
cytokin
matrix
metalloproteinas
reactiv
oxygen
speci
promot
extravas
cn
larochel
et
al
import
number
studi
use
eae
model
establish
myelinspecif
lymphocyt
activ
peripheri
acquir
molecul
enter
cn
goverman
larochel
et
al
sever
inflammatori
stimuli
eg
cytokin
induc
enhanc
express
cam
ecbbb
includ
intracellular
cell
adhes
molecul
vascular
cell
adhes
molecul
activ
leukocyt
cell
adhes
molecul
alcam
melanoma
cell
adhes
molecul
mcam
dorovinizi
cayrol
et
al
larochel
et
al
efficaci
antibodi
natalizumab
target
integrin
part
cognat
ligand
treatment
patient
ms
underlin
crucial
impact
bbbleukocyt
interact
format
ms
lesion
polman
et
al
unfortun
patient
treat
biolog
agent
wide
hamper
immun
cell
extravas
natalizumab
also
efalizumab
target
subunit
ligand
integrin
increas
risk
sever
infect
eg
jc
viru
induc
progress
multifoc
leukoencephalopathi
major
clinic
outcom
emphas
necess
develop
tool
block
migrat
specif
lymphocyt
subset
eae
model
blockad
either
alcam
mcam
upregul
ms
eae
lesion
reduc
transmigr
lymphocyt
decreas
diseas
sever
cayrol
et
al
larochel
et
al
mice
defici
mcam
specif
endotheli
cell
develop
less
sever
eae
accompani
reduc
cn
cell
infiltr
duan
et
al
moreov
mcam
express
detect
subpopul
activ
cell
produc
augment
level
inflammatori
molecul
eg
gmcsf
larochel
et
al
preferenti
migrat
across
bbb
compar
cell
devoid
molecul
larochel
et
al
schneiderhohendorf
et
al
overal
public
suggest
molecul
present
subset
inflammatori
cell
rather
wide
express
integrin
eg
integrin
integrin
could
repres
valid
therapeut
target
sever
group
investig
impact
chemokin
receptor
capac
cell
invad
cn
context
ms
anim
model
cheng
chen
well
establish
activ
lymphocyt
upregul
specif
chemokin
receptor
influenc
migratori
pattern
griffith
et
al
human
mous
cell
shown
preferenti
express
chemokin
receptor
chemokin
present
abund
choroid
plexu
normal
physiolog
ms
inflam
condit
reboldi
et
al
role
cn
inflamm
still
unresolv
conflict
result
indic
defici
mice
either
resist
eae
reboldi
et
al
exhibit
sever
eae
elhofi
et
al
villar
et
al
recent
public
suggest
region
chemokin
profil
influenc
infiltr
leukocyt
within
specif
cn
area
consequ
shape
clinic
eae
symptom
stoolman
et
al
eae
mice
exhibit
clinic
symptom
relat
brainstem
cerebellar
lesion
inde
elev
brainstem
contrast
increas
spinal
cord
eae
mice
typic
ascend
paralysi
symptom
associ
spinal
cord
immun
cell
infiltr
stoolman
et
al
moreov
anoth
group
show
follow
eae
induct
absenc
astrocytederiv
total
number
lymphocyt
inflam
cn
similar
control
howev
cell
enter
parenchym
space
confin
spinal
cord
perivascular
area
moreno
et
al
result
support
notion
cnscell
deriv
chemokin
shape
migratori
pattern
leukocyt
includ
activ
cell
addit
investig
necessari
elucid
contribut
specif
chemokin
receptor
especi
given
impact
multipl
cell
type
variou
function
numer
group
document
activ
myelin
specif
cell
secret
suffici
transfer
diseas
mice
fletcher
et
al
lovettrack
et
al
similarli
inject
patient
ms
caus
aggrav
symptom
panitch
et
al
b
key
observ
impetu
concept
myelin
specif
cell
induc
demyelin
diseas
human
ms
patient
anim
model
public
refut
key
role
cell
diseas
pathogenesi
inject
antibodi
block
augment
eae
diseas
sever
lublin
et
al
moreov
eae
induct
receptor
defici
mice
caus
sever
diseas
cours
wild
type
control
ferber
et
al
willenborg
et
al
new
subset
lymphocyt
subsequ
identifi
name
cell
lymphocyt
produc
f
amongst
mani
cytokin
eg
demonstr
cell
adopt
transfer
activ
myelinspecif
lymphocyt
induc
eae
recipi
mice
langrish
et
al
kroenk
et
al
stromn
et
al
howev
signatur
cytokin
secret
cell
dispens
eae
induct
inde
mice
defici
still
suscept
diseas
sonderegg
et
al
haak
et
al
codarri
et
al
recent
studi
pinpoint
crucial
role
granulocytemacrophag
colonystimul
factor
gmcsf
cellmedi
autoimmun
cn
inflamm
codarri
et
al
cytokin
secret
myelin
specif
activ
lymphocyt
gmcsf
defici
mice
resist
induct
eae
inject
cytokin
exacerb
diseas
symptom
wherea
administr
block
antibodi
even
diseas
onset
diminish
diseas
sever
mcqualter
et
al
codarri
et
al
elbehi
et
al
notabl
adopt
transfer
encephalitogen
cell
induc
eae
myelin
specif
cell
character
secret
also
transfer
diseas
recipi
jager
et
al
proinflammatori
cytokin
present
elev
amount
ms
patient
compar
control
inde
gmcsf
detect
csf
cn
lesion
ms
patient
especi
activ
phase
diseas
carrieri
et
al
monteyn
et
al
kebir
et
al
mellergard
et
al
fact
lymphocyt
acut
chronic
ms
lesion
express
kebir
et
al
tzarto
et
al
activ
cell
simultan
produc
preferenti
expand
blood
sampl
obtain
ms
patient
relaps
doubl
produc
cell
greater
capac
cross
human
bbb
detect
postmortem
ms
brain
tissu
kebir
et
al
moreov
key
cytokin
involv
differenti
andor
cell
subset
abund
csf
andor
cn
ms
patient
compar
control
link
li
et
al
although
inject
antibodi
target
share
subunit
provid
signific
benefit
patient
affect
autoimmun
diseas
eg
psoriasi
kumar
et
al
strategi
success
ms
patient
vollmer
et
al
recent
phase
ibiia
clinic
trial
evalu
impact
antibodi
target
gmcsf
patient
rheumatoid
arthriti
patient
shown
efficaci
behren
et
al
whether
therapi
specif
block
cytokin
gmcsf
could
benefici
ms
patient
warrant
investig
observ
eae
model
indic
rel
predomin
vs
immun
respons
influenc
cn
local
induc
inflamm
pierson
et
al
robust
respons
produc
elev
level
induc
import
immun
cell
infiltr
spinal
cord
classic
eae
symptom
eg
flaccid
tail
hindlimb
paralysi
stromn
et
al
contrast
encephalitogen
cell
secret
high
level
low
level
infiltr
preferenti
brain
parenchyma
induc
atyp
eae
symptom
eg
head
tilt
spin
axial
rotat
stromn
et
al
distinct
lesion
pattern
confirm
differ
mous
strain
inde
adopt
transfer
encephalitogen
cell
also
induc
cn
lesion
distinct
pattern
jager
et
al
numer
factor
prompt
encephalitogen
lymphocyt
preferenti
infiltr
one
particular
cn
area
includ
genet
background
myelin
epitop
target
cytokin
provid
profession
apc
local
cn
chemokin
product
cytokin
receptor
express
pierson
et
al
importantli
predomin
either
respons
ms
patient
implic
diseas
heterogen
variat
clinic
cours
respons
immunomodul
local
cn
lesion
axtel
et
al
axtel
et
al
pierson
et
al
final
increas
bodi
evid
gather
mous
model
human
studi
demonstr
plastic
activ
memori
cell
subset
commit
activ
cell
specif
function
characterist
cytokin
transcript
factor
etc
associ
particular
cell
subset
shown
irrevers
geginat
et
al
exampl
one
group
use
fate
track
system
reveal
eae
subgroup
cell
stop
produc
secret
instead
hirota
et
al
although
key
role
lymphocyt
initi
ms
eae
well
establish
cua
et
al
chen
et
al
kebir
et
al
kebir
et
al
stromn
et
al
mechan
wherebi
cell
contribut
pathogenesi
demyelin
diseas
complet
resolv
final
cell
subset
demonstr
cytotox
properti
also
contribut
tissu
damag
demonstr
proport
lymphocyt
express
well
marker
eg
granzym
b
elev
peripher
blood
ms
patient
compar
control
zaguia
et
al
moreov
cell
present
ms
lesion
could
kill
human
oligodendrocyt
express
hlae
cognat
ligand
zaguia
et
al
addit
investig
deem
essenti
elucid
contribut
numer
immun
molecul
mechan
use
lymphocyt
injur
neural
cell
pierson
et
al
despit
impos
bodi
evid
gather
eae
model
support
essenti
role
lymphocyt
develop
ms
fletcher
et
al
result
clinic
trial
demonstr
pictur
far
complex
deplet
antibodi
therapi
produc
clinic
benefit
patient
ms
lindsey
et
al
llewellynsmith
et
al
rep
et
al
van
oosten
et
al
global
immunosuppress
approach
antibodi
alemtuzumab
dramat
reduc
number
lymphocyt
success
decreas
number
relaps
diseas
progress
ms
patient
jone
et
al
emerg
appreci
contribut
lymphocyt
subset
ms
pathogenesi
warrant
investig
like
provid
accur
understand
multifacet
diseas
increas
bodi
evid
substanti
notion
lymphocyt
activ
partak
cn
injuri
observ
patient
ms
mar
et
al
sever
group
document
presenc
activ
lymphocyt
perivascular
parenchym
ms
lesion
fig
number
reach
surpass
cell
hauser
et
al
gay
et
al
babb
et
al
neumann
et
al
lassmann
junker
et
al
frischer
et
al
lymphocyt
even
detect
earli
stage
cortic
demyelin
ms
lesion
lucchinetti
et
al
produc
lymphocyt
ie
shown
enrich
especi
activ
ms
lesion
kebir
et
al
tzarto
et
al
moreov
recent
report
frequenc
mcam
express
cell
elev
ms
patient
relaps
proport
mcam
cell
produc
gmcsf
tnf
significantli
greater
mcamneg
counterpart
larochel
et
al
clonal
divers
lymphocyt
present
specif
compart
assess
spectratyp
analysi
complementar
determin
region
tcr
clone
express
distinct
sequenc
number
distinct
cell
clone
detect
specif
organ
limit
impli
cell
inadvert
move
compart
rather
antigenspecif
lymphocyt
preferenti
infiltr
local
expand
sever
group
analyz
tcr
repertoir
lymphocyt
obtain
blood
csf
andor
brain
ms
patient
studi
found
major
lymphocyt
recov
ms
lesion
belong
clone
babb
et
al
junker
et
al
furthermor
use
sampl
obtain
patient
studi
longitudin
possibl
establish
cell
clone
detect
ms
patient
persist
year
cn
csf
andor
tissu
jacobsen
et
al
skulina
et
al
sharp
contrast
repertoir
cell
recov
cn
ms
patient
shown
heterogen
babb
et
al
jacobsen
et
al
skulina
et
al
junker
et
al
overal
report
reinforc
idea
lymphocyt
present
cn
ms
patient
bystand
cell
rather
engag
activ
immun
respons
mar
et
al
howev
antigen
recogn
infiltr
cell
potenti
lead
activ
expans
cn
identifi
lymphocyt
recogn
antigen
present
mhc
class
molecul
genet
studi
indic
specif
mhc
class
allel
either
increas
eg
hlaa
reduc
hlaa
risk
develop
ms
fogdellhahn
et
al
harbo
et
al
bryned
et
al
rubio
et
al
suggest
mhc
class
allel
could
influenc
activ
selfreact
lymphocyt
fugger
et
al
mar
et
al
normal
physiolog
condit
mhc
class
molecul
either
undetect
cn
cell
express
low
level
microglia
endotheli
cell
sharp
contrast
inflammatori
condit
observ
cn
ms
patient
upregul
molecul
neuron
oligodendrocyt
astrocyt
even
earli
phase
diseas
ransohoff
est
gobin
et
al
hoftberg
et
al
therefor
specul
activ
cell
directli
target
resid
cn
cell
inde
sever
group
identifi
ms
lesion
cell
close
proxim
oligodendrocyt
demyelin
axon
polar
cytolyt
granul
neumann
et
al
wulff
et
al
lassmann
saikali
et
al
cell
detect
posit
correl
extent
axon
damag
bitsch
et
al
kuhlmann
et
al
moreov
primari
cultur
system
activ
cell
abl
injur
neuron
axon
sauer
et
al
well
oligodendrocyt
jurewicz
et
al
antigenmhc
class
specif
manner
furthermor
myelinspecif
cell
induc
mice
demyelin
diseas
patholog
featur
reminisc
human
ms
diseas
husebi
et
al
sun
et
al
fries
fugger
well
murin
virusinduc
model
demyelin
diseas
eg
theiler
viru
mous
hepat
viru
support
involv
cell
demyelin
axon
injuri
murray
et
al
wu
et
al
howe
et
al
collect
result
emphas
contribut
lymphocyt
cn
injuri
observ
ms
patient
howev
cytotox
lymphocyt
like
act
alon
inde
experiment
data
illustr
lymphocyt
work
concert
mediat
autoimmun
attack
observ
eae
huber
et
al
therefor
deem
essenti
investig
interplay
lymphocyt
differ
stage
ms
anim
model
studi
like
shed
light
complex
heterogen
immun
mechan
involv
ms
pathobiolog
regulatori
lymphocyt
crucial
maintain
peripher
toler
consequ
prevent
autoimmun
diseas
cell
curtail
function
multipl
immun
cell
subset
includ
lymphocyt
natur
killer
cell
nk
apc
eg
monocyt
macrophag
dendrit
cell
via
direct
contact
secret
molecul
lowther
hafler
fig
lymphocyt
subset
regulatori
properti
identifi
jadidiniaragh
mirshafiey
studi
regulatori
cell
subset
context
ms
anim
model
natur
occur
regulatori
cell
express
transcript
factor
treg
ii
regulatori
cell
secret
kleinewietfeld
hafler
sever
investig
perform
eae
model
establish
regulatori
lymphocyt
influenc
develop
sever
diseas
also
favor
recoveri
phase
olivaresvillagomez
et
al
kohm
et
al
mcgeachi
et
al
inde
adopt
transfer
treg
mice
confer
protect
eae
induct
deplet
cell
led
sever
diseas
cours
kohm
et
al
reddi
et
al
other
report
deplet
reg
influenc
first
eae
remiss
phase
eae
mice
rather
reduc
develop
subsequ
relaps
gartner
et
al
jadidiniaragh
mirshafiey
similarli
inject
mice
produc
cell
activ
via
differ
protocol
prevent
eae
induct
barrat
et
al
ding
et
al
numer
group
investig
reg
cell
peripher
blood
obtain
ms
patient
found
regulatori
cell
impair
regulatori
function
migratori
properti
necessarili
alter
frequenc
compar
sampl
taken
healthi
donor
viglietta
et
al
astier
et
al
martinezforero
et
al
venken
et
al
schneiderhohendorf
et
al
howev
activ
cell
express
high
level
liu
et
al
seddiki
et
al
subtract
reg
defin
high
low
analyz
suppress
capac
reg
ms
patient
found
either
similar
healthi
individu
venken
et
al
baecherallan
et
al
reduc
earli
ms
patient
diseas
durat
less
year
compar
healthi
control
venken
et
al
potenti
use
antibodi
remov
activ
cell
reg
current
investig
ms
patient
wwwclinicaltrailsgov
final
increas
number
public
indic
human
express
reg
repres
homogen
popul
express
addit
transcript
factor
eg
helio
surfac
marker
eg
tigit
associ
suppress
capac
shevach
thornton
bin
dhuban
et
al
investig
necessari
determin
whether
specif
reg
subset
ms
patient
alter
compar
healthi
control
interestingli
immunomodulatori
treatment
ms
patient
shown
mediat
least
part
posit
impact
revers
alter
properti
regulatori
cell
patient
de
andr
et
al
korpor
et
al
haa
et
al
chiarini
et
al
observ
suggest
restor
function
regulatori
cell
patient
repres
promis
therapeut
option
kleinewietfeld
hafler
exampl
first
broadli
use
immunomodulatori
therapi
treat
ms
patient
shown
favor
secret
dendrit
cell
sweeney
et
al
remark
monocytederiv
dendrit
cell
obtain
ms
patient
character
respond
produc
significantli
obtain
nonrespond
sweeney
et
al
similarli
benefici
immunoregulatori
impact
eae
shown
reli
induc
product
guo
et
al
shinohara
et
al
notabl
reduc
eae
sever
via
sever
mechan
includ
differenti
cell
awasthi
et
al
fitzgerald
et
al
stumhof
et
al
vasanthakumar
kalli
subpopul
cell
exhibit
regulatori
properti
report
human
anim
model
although
knowledg
cell
extens
counterpart
unfortun
marker
eg
cytokin
link
regulatori
lymphocyt
specif
cell
suppress
capac
jiang
chess
will
fries
hu
et
al
almost
thirti
year
ago
impair
cell
suppressor
function
report
ms
patient
compar
healthi
control
antel
et
al
antel
et
al
recent
lymphocyt
bear
capac
kill
myelin
specif
lymphocyt
hlae
restrict
fashion
describ
correal
villa
especi
ms
patient
treat
glatiram
acet
synthet
copolym
four
amino
acid
tennakoon
et
al
similarli
human
data
capac
regulatori
cell
suppress
autoreact
cell
via
mechan
involv
molecul
mous
equival
human
hlae
shown
eae
jiang
et
al
lu
et
al
karantikar
colleagu
describ
cn
antigen
specif
cell
abl
suppress
prolifer
effector
cell
cellmedi
suppress
reduc
sampl
ms
patient
obtain
acut
diseas
exacerb
compar
healthi
control
nonact
ms
patient
baughman
et
al
neg
cell
subpopul
identifi
regulatori
cell
subset
capac
protect
eae
najafian
et
al
lee
et
al
yu
et
al
overal
studi
indic
regulatori
cell
subset
potenti
regul
detriment
autoimmun
respons
observ
activ
ms
patient
anim
model
howev
mechan
wherebi
cell
accomplish
benefici
impact
need
investig
microbiota
refer
ensembl
microorgan
resid
given
anatom
locat
bodi
bhargava
mowri
semin
public
document
impact
specif
gut
bacteri
commun
immun
system
includ
lymphocyt
inde
commens
microorgan
promot
either
inflammatori
regulatori
cell
respons
atarashi
et
al
atarashi
et
al
kawamoto
et
al
addit
direct
impact
gut
microbiota
bowelrel
disord
grow
bodi
evid
suggest
microorgan
modul
autoimmun
disord
remot
organ
cn
berer
krishnamoorthi
bhargava
mowri
epidemiolog
genet
biolog
studi
reveal
suscept
ms
diseas
dictat
intric
interplay
gene
environment
factor
recent
research
commun
turn
spotlight
gut
commens
microbiota
potenti
environment
risk
factor
ms
berer
krishnamoorthi
bhargava
mowri
modul
gut
microbiota
mice
shown
influenc
suscept
eae
follow
oral
antibiot
regimen
dramat
reduc
gastrointestin
bacteri
popul
mice
found
significantli
less
suscept
eae
induct
delay
onset
attenu
diseas
sever
compar
control
ochoareparaz
et
al
lee
et
al
similarli
oral
antibiot
treatment
given
mice
gener
spontan
develop
eae
due
transgen
express
tcr
recogn
myelin
epitop
abolish
develop
cn
diseas
berer
et
al
protect
induc
erad
gut
microbiota
link
mechan
increas
number
regulatori
cell
reduc
popul
cell
impair
abil
dendrit
cell
activ
respons
ochoareparaz
et
al
berer
et
al
lee
et
al
moreov
adopt
transfer
lymphocyt
antibiotictr
mice
recipi
eae
induct
decreas
diseas
sever
cell
nontreat
donor
alter
eae
suscept
ochoareparaz
et
al
recolonis
germfre
mice
segment
filament
bacteria
shown
promot
cell
activ
suffici
restor
suscept
eae
induct
lee
et
al
contrast
oral
administr
capsular
polysaccharid
bacteroid
fragili
pediococcu
acidilactici
strain
known
reduc
intestin
inflamm
induc
cell
reduc
eae
diseas
sever
ochoareparaz
et
al
takata
et
al
overal
report
indic
least
rodent
model
specif
gut
bacteria
bacteri
product
skew
cell
respons
thu
influenc
whether
detriment
autoimmun
respons
target
distant
cn
take
place
studi
investig
impact
gut
microorgan
ms
pathobiolog
correal
farez
show
ms
patient
infect
intestin
parasit
alter
gut
microbiota
also
induc
robust
respons
significantli
reduc
number
relaps
compar
uninfect
ms
patient
farez
clostridium
perfringen
type
b
usual
associ
gastrointestin
diseas
rumin
isol
patient
ms
first
clinic
present
rumah
et
al
interestingli
bacteria
produc
epsilon
toxin
neurotox
anim
bokoribrown
et
al
antibodi
target
toxin
preval
sera
ms
patient
healthi
control
rumah
et
al
whether
bacteria
clostridium
genu
modul
immun
respons
ms
patient
still
unknown
recent
uncov
diet
pattern
high
salt
diet
increas
eae
sever
kleinewietfeld
et
al
moreov
longterm
well
shortterm
chang
human
diet
shown
modifi
human
gut
microbiota
david
et
al
diet
shape
gut
microbiota
influenc
immun
cell
respons
specul
diet
pattern
favor
specif
microbi
popul
could
lead
dampen
andor
respons
diet
could
support
growth
microbi
popul
promot
inflammatori
respons
commens
gut
flora
shown
essenti
expans
mucosalassoci
invari
cell
mait
treiner
et
al
innatelik
cell
express
invari
chain
human
found
mucos
tissu
also
organ
eg
liver
peripher
blood
treiner
et
al
dusseaux
et
al
le
bourhi
et
al
gapin
human
mait
express
high
level
cytokin
receptor
produc
inflammatori
cytokin
includ
gapin
annibali
colleagu
observ
elev
proport
hi
cell
peripher
blood
ms
patient
compar
control
annibali
et
al
contrast
group
detect
significantli
reduc
frequenc
hi
express
cell
miyazaki
et
al
hi
cell
will
et
al
blood
ms
patient
compar
healthi
control
will
colleagu
suggest
inconsist
studi
could
due
variat
donor
age
observ
diminish
proport
mait
age
healthi
donor
will
et
al
notabl
frequenc
mait
significantli
reduc
ms
patient
follow
immunosuppress
therapi
abrahamsson
et
al
moreov
cell
express
produc
annibali
et
al
express
chain
abrahamsson
et
al
will
et
al
detect
postmortem
cn
tissu
ms
patient
whether
mait
contribut
patholog
process
observ
ms
patient
still
unresolv
final
whether
impact
gut
microbiota
specif
immun
cell
subset
immun
cell
subset
modul
develop
ms
unknown
investig
deem
essenti
determin
whether
gut
microbiota
inde
key
factor
ms
pathogenesi
could
modul
alter
diseas
berer
krishnamoorthi
bhargava
mowri
glial
cell
includ
astrocyt
oligodendrocyt
microglia
perform
highli
complex
complementari
function
ultim
goal
provid
support
protect
optim
condit
neuron
microglia
resid
innat
immun
cell
cn
consequ
provid
first
line
defens
endogen
exogen
insult
giunti
et
al
normal
physiolog
condit
rest
microglia
constantli
scrutin
surround
remov
cell
debri
sens
potenti
threat
via
plethora
receptor
tolllik
receptor
scaveng
receptor
goldmann
prinz
giunti
et
al
strachanwhaley
et
al
grow
bodi
evid
suggest
activ
microglia
one
earliest
stage
develop
ms
lesion
even
prior
infiltr
monocytesmacrophag
lymphocyt
van
noort
et
al
strachanwhaley
et
al
use
biomark
activ
microglia
investig
perform
pet
imag
ms
patient
well
clinic
isol
syndrom
patient
first
episod
cn
demyelin
observ
increas
microgli
activ
lesion
also
normal
appear
white
matter
patient
compar
healthi
subject
politi
et
al
giannetti
et
al
similarli
use
multipl
techniqu
immunohistochemistri
flow
cytometri
twophoton
microscopi
sever
group
report
activ
microglia
preced
infiltr
macrophag
cell
eae
model
ponomarev
et
al
davalo
et
al
giunti
et
al
given
immun
properti
express
mhc
class
class
ii
molecul
product
cytokin
well
distribut
throughout
cn
microglia
uniqu
posit
influenc
modul
respons
cn
infiltr
immun
cell
especi
lymphocyt
almolda
et
al
strachanwhaley
et
al
inflam
cn
activ
microglia
infiltr
macrophag
exhibit
similar
properti
function
thu
often
undistinguish
techniqu
immunohistochem
analysi
author
review
numer
protect
benefici
effect
microglia
ms
anim
model
goldmann
prinz
giunti
et
al
strachanwhaley
et
al
briefli
discuss
crosstalk
lymphocyt
microgliainfiltr
macrophag
context
demyelin
diseas
microglia
macrophag
abundantli
present
white
matter
cortic
demyelin
lesion
ms
eae
cell
often
detect
close
proxim
lymphocyt
lucchinetti
et
al
huck
et
al
lassmann
support
likelihood
activ
interact
cell
subset
import
number
studi
document
human
rodent
activ
microglia
immun
compet
cell
effici
present
antigen
lymphocyt
aloisi
et
al
carson
et
al
almolda
et
al
jarri
et
al
strachanwhaley
et
al
wlodarczyk
et
al
therefor
microglia
contribut
initi
activ
cell
also
local
restimul
infiltr
activ
cell
activ
microglia
express
elev
level
mhc
class
class
ii
molecul
sever
costimulatori
molecul
includ
william
et
al
raivich
banati
almolda
et
al
goldmann
prinz
giunti
et
al
strachanwhaley
et
al
wlodarczyk
et
al
molecul
engag
physic
contact
cell
microglia
trigger
activ
signal
pathway
cell
moreov
specif
subset
activ
microglia
shown
secret
cytokin
favor
either
cell
subset
eg
tnf
jack
et
al
strachanwhaley
et
al
although
cytokin
level
produc
activ
microglia
lower
produc
macrophag
wlodarczyk
et
al
contrast
specif
vitro
cultur
condit
microglia
promot
develop
regulatori
lymphocyt
express
capac
protect
eae
upon
adopt
transfer
mice
ebner
et
al
final
microglia
acquir
proinflammatori
phenotyp
produc
tnf
antiinflammatori
phenotyp
produc
show
enhanc
myelin
phagocytosi
capac
origin
describ
macrophag
durafourt
et
al
nakagawa
chiba
publish
report
suggest
microglia
macrophag
favor
repair
recoveri
eae
model
mikita
et
al
strachanwhaley
et
al
overal
result
suggest
activ
microglia
local
either
establish
local
inflammatori
milieu
sustain
activ
inflammatori
lymphocyt
matyszak
et
al
giunti
et
al
favor
regulatori
antiinflammatori
lymphocyt
strachanwhaley
et
al
crosstalk
microglia
cell
also
shape
microgli
properti
strachanwhaley
et
al
wherea
murin
myelin
autoreact
cell
trigger
secret
proinflammatori
molecul
tnf
nitrit
microglia
myelin
autoreact
cell
induc
express
neurotroph
factor
brainderiv
neurotroph
factor
cell
roy
et
al
moreov
infiltr
produc
cell
eae
concur
elev
product
inflammatori
cytokin
tnf
like
microglia
furthermor
cell
caus
elev
mhc
class
ii
express
microglia
vitro
murphi
et
al
collect
result
illustr
crosstalk
lymphocyt
microglia
lead
detriment
benefici
effect
contribut
pathobiolog
ms
anim
model
studi
deem
essenti
understand
intric
cellmicroglia
dialogu
especi
sinc
sever
activ
cell
subset
reg
capac
migrat
cn
increas
number
public
underlin
role
astrocyt
modul
cell
respons
especi
context
ms
anim
model
mayo
et
al
detail
descript
literatur
beyond
scope
current
review
howev
least
mention
astrocyt
produc
cytokin
chemokin
express
molecul
alter
cell
respons
mayo
et
al
exampl
shown
astrocyt
ms
lesion
express
elev
level
mediat
either
inhibit
enhanc
cell
respons
use
vitro
assay
saikali
et
al
pittet
et
al
although
convinc
data
demonstr
astrocyt
effici
present
antigen
cell
abund
glial
cell
significantli
alter
cn
inflamm
last
decad
progress
achiev
scientif
commun
elucid
complex
immun
mechan
involv
pathobiolog
ms
remark
major
advanc
includ
identif
character
cell
subset
eg
regulatori
cell
molecul
eg
cytokin
chemokin
cell
adhes
molecul
interact
cn
cell
eg
bbbec
microglia
astrocyt
contribut
prototyp
inflammatori
diseas
cn
potenti
extent
neurolog
diseas
moreov
develop
addit
rodent
model
mirror
intricaci
multifacet
human
diseas
provid
continu
provid
invalu
insight
examin
caus
underli
diseas
heterogen
patient
review
present
overview
impress
bodi
evid
advoc
lymphocyt
particip
develop
ms
anim
model
highlight
increas
number
public
substanti
contribut
immun
factor
b
lymphocyt
antibodi
develop
demyelin
diseas
krumbholz
et
al
spite
great
number
mileston
reach
elucid
ms
immunopathobiolog
exact
etiolog
ms
yet
defin
moreov
despit
increas
number
avail
immunomodulatori
immunosuppress
therapi
alter
ms
progress
still
cure
avail
therefor
scientif
commun
continu
hunt
potenti
immun
mechan
target
prevent
also
erad
ms
activ
role
lymphocyt
pathogenesi
ms
eae
contrast
organ
brain
spinal
cord
contain
defin
lymphat
channel
nevertheless
lymphat
drainag
csf
interstiti
fluid
brain
parenchyma
cervic
lymph
node
take
place
laman
weller
solubl
cn
antigen
profession
apc
dendrit
cell
engulf
myelin
neuron
antigen
travel
cn
cervic
lymph
node
cln
mohammad
et
al
matur
apc
engulf
myelin
neuron
antigen
detect
cervic
lymph
node
obtain
ms
patient
eae
anim
laman
weller
apc
effici
activ
cnsreactiv
lymphocyt
differ
regulatori
lymphocyt
subset
shown
reduc
develop
sever
eae
kleinewietfeld
hafler
sinha
et
al
sever
group
report
regulatori
cell
subset
ms
patient
impair
regulatori
function
compar
healthi
donor
kleinewietfeld
hafler
sinha
et
al
activ
myelin
neuronalspecif
lymphocyt
exit
peripher
blood
perform
immunosurveil
cn
reactiv
lymphocyt
obtain
peripher
blood
ms
patient
exhibit
enhanc
activ
properti
compar
health
donor
activ
autoreact
lymphocyt
enhanc
capac
cross
bbb
given
elev
express
mediat
chemokin
receptor
adhes
molecul
integrin
cytokin
goverman
larochel
et
al
cn
lymphocyt
reactiv
local
apc
macrophag
microglia
dendrit
cell
b
lymphocyt
present
human
mous
cn
lesion
greter
et
al
frohman
et
al
pierson
et
al
antigenspecif
reactiv
shown
essenti
licens
activ
autoreact
lymphocyt
enter
cn
parenchyma
bartholomau
et
al
cn
infiltr
lymphocyt
macrophag
well
inflam
microglia
secret
solubl
mediat
eg
inflammatori
cytokin
free
radic
etc
moreov
crosstalk
cell
microgliamacrophag
contribut
perpetu
inflammatori
milieu
within
cn
solubl
mediat
injur
oligodendrocytemyelin
axonneuron
structur
moreov
activ
microgliamacrophag
directli
phagocyt
oligodendrocyt
similarli
lymphocyt
detect
close
proxim
oligodendrocyt
demyelin
axon
polar
cytolyt
granul
neumann
et
al
wulff
et
al
lassmann
saikali
et
al
activ
cell
capac
kill
oligodendrocyt
neuron
jurewicz
et
al
sauer
et
al
zaguia
et
al
final
damag
caus
releas
addit
cn
antigen
phagocytos
present
new
wave
cnsspecif
lymphocyt
